FiercePharma3d
Savara, eyeing rare disease drug submission next year, nabs Orchard's commercial lead to steer launch
Savara says it will in the first of half next year seek an FDA license to treat autoimmune pulmonary alveolar proteinosis ...
Savara Appoints Braden Parker as Chief Commercial Officer, Effective Immediately
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...
Zoomcar Announces First Annual Stockholder Meeting 2024
Zoomcar, Zoomcar Holdings, Inc. ("Zoomcar" or the "Company") (NASDAQ: ZCAR), the NASDAQ-listed leading marketplace for self-drive car sharing, announced that it will hold its first Annual Stockholder ...
Savara Announces New Employment Inducement Grant
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced ...